Executive interview: Celebrating 10 years of Molly enabling patients' independence

SHL Medical is pleased to announce its latest feature in the Delivering Injectables: Devices and Formulations issue of ONdrug Delivery magazine. In this edition, SHL Medical’s Global Head of Sales, Nicholas Heaton, reflects on a major milestone in an executive interview celebrating 10 years of Molly enabling patients’ independence.

Titled “Celebrating 10 Years of Molly Enabling Patients’ Independence,” the interview explores the evolution of the Molly autoinjector platform over the past decade, highlighting how patient-centric innovation and SHL Medical’s commitment to delivering reliable, scalable drug delivery solutions have supported its pharma customers and improved the patient experience worldwide.

As Nicholas Heaton shares in the interview: “10 years later, Molly is a well-established global platform that has enabled the regulatory approval of more than 20 combination products, covering nearly 30 therapeutic indications and still growing.”

The interview also discusses the growing demand for advanced drug delivery solutions and SHL Medical’s continued commitment to pushing the boundaries of the Molly platform through ongoing improvements in functionality, reliability, and development efficiency. These advancements help customers bring therapies to market quickly and efficiently without compromising on quality.

Download the full interview to learn more